Peijia Medical (沛嘉医疗) IPO Trading: Action for the High Flyer
Peijia Medical raised HKD 2.2 billion (USD 283 m) from its global offering and will list on the stock exchange tomorrow. In our previous insight,...
556 Views
Peijia Medical IPO: Valuation Insights
Peijia Medical (9996 HK) is a leading transcatheter heart valve medical device company in China. Peijiahas launched a Hong Kong IPO to raise net...
523 Views
Peijia Medical (沛嘉医疗) IPO: Hot Deal at Discount
Peijia Medical launched book building to raise up to USD 302 million to list in Hong Kong. It is a leading domestic player in the transcatheter...
603 Views
Peijia Medical (沛嘉医疗) Pre-IPO: Deserves Valuation Premium for the TAVR Late Comer
Peijia Medical is a leading domestic player in the transcatheter valve therapeutic medical device market and the neurointerventional procedural...
654 Views
Peijia Medical IPO Initiation: Let's Have a Heart-To-Heart
Peijia Medical (1740651D CH) is a leading transcatheter heart valve medical device company in China. It has filed for a Hong Kong IPO and is...
486 Views